NCT07099066View on ClinicalTrials.gov

Generation of Cell Banks and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (ALS) (HCD-SLA)

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
OTHER

sampling blood

3 types of sampling : urine, skin and blood.

Sponsors

Lead Sponsor

Human Cell Design
All Listed Sponsors
lead

Human Cell Design

INDUSTRY